Hypertension is the most common disease affecting humans and imparts a significant cardiovascular and renal risk to patients. Extensive research over the past few decades has enhanced our understanding of the underlying mechanisms in hypertension. However, in most instances, the cause of hypertension in a given patient continues to remain elusive. Nevertheless, achieving aggressive blood pressure goals significantly reduces cardiovascular morbidity and mortality, as demonstrated in the recently concluded SPRINT trial. Since a large proportion of patients still fail to achieve blood pressure goals, knowledge of novel pathophysiologic mechanisms and mechanism based treatment strategies is crucial. The following chapter will review the novel pathophysiological mechanisms in hypertension, with a focus on role of immunity, inflammation and vascular endothelial homeostasis. The therapeutic implications of these mechanisms will be discussed where applicable.
CITATION STYLE
Samson, R., Lee, A., Lawless, S., Hsu, R., & Sander, G. (2017). Novel pathophysiological mechanisms in hypertension. In Advances in Experimental Medicine and Biology (Vol. 956, pp. 21–35). Springer New York LLC. https://doi.org/10.1007/5584_2016_96
Mendeley helps you to discover research relevant for your work.